Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 211 AL 225

Masitinib for the treatment of mild to moderate Alzheimer's disease

Folch J, Petrov D, Ettcheto M, Pedrós I, Abad S, Beas-Zarate C, Lazarowski A, Marin M, Olloquequi J, Auladell C, Camins A.

Expert Rev Neurother. 2015 Jun;15(6):587-96. doi: 10.1586/14737175.2015.1045419. Epub 2015 May 11.

Drug repositioning in Alzheimer's disease

Corbett A, Williams G, Ballard C.

Front Biosci (Schol Ed). 2015 Jun 1;7(1):184-8. doi: 10.2741/S432.

Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer's Disease

Faldu KG, Shah JS, Patel SS.

Recent Pat Antiinfect Drug Discov. 2015;10(2):76-83. doi: 10.2174/1574891x10666150509193236.

[Using a film to learn about Alzheimer's]

Dumont M.

Soins Gerontol. 2015 Mar-Apr;(112):1.

Beneficial Effect of Flavone Derivatives on Aβ-Induced Memory Deficit Is Mediated by Peroxisome Proliferator-Activated Receptor γ Coactivator 1α: A Comparative Study

Arsalandeh F, Ahmadian S, Foolad F, Khodagholi F, Farimani MM, Shaerzadeh F.

Int J Toxicol. 2015 May-Jun;34(3):274-83. doi: 10.1177/1091581815584165. Epub 2015 May 13.

Alzheimer's pathogenesis and its link to the mitochondrion

Simoncini C, Orsucci D, Caldarazzo Ienco E, Siciliano G, Bonuccelli U, Mancuso M.

Oxid Med Cell Longev. 2015;2015:803942. doi: 10.1155/2015/803942. Epub 2015 Apr 20.

Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer's Disease

Ajith TA, Padmajanair G.

Curr Aging Sci. 2015;8(3):235-40. doi: 10.2174/187460980803151027115147.

New cardiovascular targets to prevent late onset Alzheimer disease

Claassen JA.

Eur J Pharmacol. 2015 Sep 15;763(Pt A):131-4. doi: 10.1016/j.ejphar.2015.05.022. Epub 2015 May 15.

Therapeutic Effects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer's Disease

Cheung TS, Song TH, Ng TB, Wu FH, Lao LX, Tang SC, Ho JC, Zhang KY, Sze SC.

Curr Med Chem. 2015;22(19):2392-403. doi: 10.2174/0929867322666150520095509.

Immune attack: the role of inflammation in Alzheimer disease

Heppner FL, Ransohoff RM, Becher B.

Nat Rev Neurosci. 2015 Jun;16(6):358-72. doi: 10.1038/nrn3880.

The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin

Folch J, Patraca I, Martínez N, Pedrós I, Petrov D, Ettcheto M, Abad S, Marin M, Beas-Zarate C, Camins A.

Life Sci. 2015 Nov 1;140:19-28. doi: 10.1016/j.lfs.2015.05.002. Epub 2015 May 19.

Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

Liang J, Kulasiri D, Samarasinghe S.

Biosystems. 2015 Aug;134:1-15. doi: 10.1016/j.biosystems.2015.05.003. Epub 2015 May 19.

Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape

Salminen A, Haapasalo A, Kauppinen A, Kaarniranta K, Soininen H, Hiltunen M.

Prog Neurobiol. 2015 Aug;131:1-20. doi: 10.1016/j.pneurobio.2015.05.001. Epub 2015 May 19.

Cohesion and the aneuploid phenotype in Alzheimer's disease: A tale of genome instability

Bajic V, Spremo-Potparevic B, Zivkovic L, Isenovic ER, Arendt T.

Neurosci Biobehav Rev. 2015 Aug;55:365-74. doi: 10.1016/j.neubiorev.2015.05.010. Epub 2015 May 21.

The case for rejecting the amyloid cascade hypothesis

Herrup K.

Nat Neurosci. 2015 Jun;18(6):794-9. doi: 10.1038/nn.4017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias